Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Hernández-Huerta

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Psychiatry Research|July 31, 2021
Impact of the COVID-19 pandemic on acute inpatient psychiatric units in SpainJosé Manuel Montes, Daniel Hernández-Huerta
Neuropsychiatric Disease and Treatment|February 11, 2021
Cariprazine in Three Acute Patients with Schizophrenia: A Real-World ExperienceJose M Montes, Paloma Montes, Daniel Hernández-Huerta
Behavioral Sciences (Basel, Switzerland)|December 22, 2022
Chemsex and Psychosis: A Systematic ReviewLucía Moreno-Gámez, Daniel Hernández-Huerta, Guillermo Lahera
Adicciones|January 11, 2019
Influence of substance use and cognitive impairment on adherence to antiretroviral therapy in HIV+ patientsIrene Sánchez-Rivero, Agustín Madoz-Gúrpide, Carlos Parro-Torres, et al.
Adicciones|July 28, 2017
Relationship between alcohol consumption, whether linked to other substance use or not, and antiretroviral treatment adherence in HIV+ patientsSara González-Álvarez, Agustín Madoz-Gúrpide, Carlos Parro-Torres, et al.
Journal of Psychosomatic Research|March 12, 2021
Personality and adherence to antiretroviral therapy in HIV-infected adult patientsDaniel Hernández-Huerta, Carlos Parro-Torres, Agustín Madoz-Gúrpide, et al.
AIDS Care|June 24, 2021
Antiretroviral treatment adherence and mental disorders: observational case-control study in people living with HIV in SpainCarlos Parro-Torres, Daniel Hernández-Huerta, Enriqueta Ochoa-Mangado, et al.
International Journal of Psychiatry in Clinical Practice|July 6, 2022
Aripiprazole for the treatment of schizophrenia: Recommendations of a panel of Spanish experts on its use in clinical practiceDavid Fraguas, David Almenta Gallego, Sergio Arques-Egea, et al.
Journal of Psychopharmacology (Oxford, England)|August 8, 2024
Compassionate use of esketamine intranasal in patients with severe major depressive disorder resistant to the treatmentLuis Gutiérrez-Rojas, Julia Vendrell-Serres, J Antoni Ramos-Quiroga, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Psychiatry Research|July 31, 2021
Impact of the COVID-19 pandemic on acute inpatient psychiatric units in SpainJosé Manuel Montes, Daniel Hernández-Huerta
Neuropsychiatric Disease and Treatment|February 11, 2021
Cariprazine in Three Acute Patients with Schizophrenia: A Real-World ExperienceJose M Montes, Paloma Montes, Daniel Hernández-Huerta
Behavioral Sciences (Basel, Switzerland)|December 22, 2022
Chemsex and Psychosis: A Systematic ReviewLucía Moreno-Gámez, Daniel Hernández-Huerta, Guillermo Lahera
Adicciones|January 11, 2019
Influence of substance use and cognitive impairment on adherence to antiretroviral therapy in HIV+ patientsIrene Sánchez-Rivero, Agustín Madoz-Gúrpide, Carlos Parro-Torres, et al.
Adicciones|July 28, 2017
Relationship between alcohol consumption, whether linked to other substance use or not, and antiretroviral treatment adherence in HIV+ patientsSara González-Álvarez, Agustín Madoz-Gúrpide, Carlos Parro-Torres, et al.
Journal of Psychosomatic Research|March 12, 2021
Personality and adherence to antiretroviral therapy in HIV-infected adult patientsDaniel Hernández-Huerta, Carlos Parro-Torres, Agustín Madoz-Gúrpide, et al.
AIDS Care|June 24, 2021
Antiretroviral treatment adherence and mental disorders: observational case-control study in people living with HIV in SpainCarlos Parro-Torres, Daniel Hernández-Huerta, Enriqueta Ochoa-Mangado, et al.
International Journal of Psychiatry in Clinical Practice|July 6, 2022
Aripiprazole for the treatment of schizophrenia: Recommendations of a panel of Spanish experts on its use in clinical practiceDavid Fraguas, David Almenta Gallego, Sergio Arques-Egea, et al.
Journal of Psychopharmacology (Oxford, England)|August 8, 2024
Compassionate use of esketamine intranasal in patients with severe major depressive disorder resistant to the treatmentLuis Gutiérrez-Rojas, Julia Vendrell-Serres, J Antoni Ramos-Quiroga, et al.
Pageof 1